
Maya Abdallah
@MayaAbdallah_MD
Followers
952
Following
2K
Media
61
Statuses
498
Geri Heme/Onc @BUMedicine @The_BMC | @ASCOTECAG Member | Former @ASH_hematology Trainee Council Chair | Proud #IMG 🇱🇧🇺🇸
Joined April 2019
RT @Abdallah81MD: 🚨 Tocilizumab Prophylaxis for Patients with Multiple Myeloma Treated with Bispecific Antibodies.Critical to Move all Futu….
0
29
0
RT @ramsedhom: 🎗️ Cancer & Aging: What Every Family Should Know.🗓️ June 13 | 7:30 AM–12:30 PM.📍 Mercer County Community College.Free event….
0
2
0
RT @sakhrabdulsalam: A powerful session at #ASCO25. #InspiringVoices. And trust me, you are #NOT alone on this journey . @Noha_Soror @IMG_O….
0
4
0
RT @IMG_Oncologists: 🔥 We’re back with “Empowering IMGs: Perspectives of IMG Leaders”. Join Drs. Choueiri, Dizman, Bakouny, Cascone, Varell….
0
13
0
RT @NazliDizman: Join us @ASCO #ASCO25 #IMGoncCoP meeting!. 📅5/30 Friday.⏰4-6 pm .📌Room S103 McCormick Place. @DrChoueiri @ZiadBakouny #IMG….
0
11
0
RT @IMG_Oncologists: 🚨Save the date🚨.@ASCO #IMG Community of Practice Meeting at #ASCO25.⏰May 30st, 4-6 PM CST.📌Room S103, McCormick Place….
0
41
0
RT @YaleCancer: Thank you to Dr. J. Mark Sloan @Jmarksloan @BUMedicine for presenting the #BoveLecture @YaleCancer #GrandRounds. View his f….
0
5
0
RT @IvyLorena_Md: We encourage you to check out our article on tips for finding a HemeOnc job in the U.S. while on a J1 visa. It offers pra….
0
18
0
#ALF2025 was fantastic - I learned so much from MDS & AML experts! . Truly honored to co-moderate the Multidisciplinary Care in AML session. Big thanks to my incredible mentor & ALF co-chair Dr. @CarrawayHetty & to co-chairs Drs. Stein & @DanPollyea for the kind invitation!
2
5
44
RT @MikkaelSekeres: Terrific Acute Leukemia Forum @Medscape meeting! With outstanding chairs @CarrawayHetty @DanPollyea and Eytan Ste….
0
7
0
RT @Jmarksloan: Even grade 3+ neutropenia is of little importance in an era of targeted therapy. You can see this by looking at AEs of….
www.nejm.org
Whether fixed-duration acalabrutinib–venetoclax (with or without obinutuzumab) would result in better progression-free survival than chemoimmunotherapy in patients with untreated chronic lymphocyti...
0
2
0
RT @CULymphoma: Dr. @majorajay @CULymphoma published an invited review on how to integrate patient-reported outcomes into hematology clinic….
0
7
0
RT @Abdallah81MD: In the US, there are more than 30,000 Hematologists and Oncologists actively practicing, with 37% of them being Internati….
0
3
0
RT @ASH_hematology: #ASHSlideSaturday 🩸: Analyze this bone marrow smear from the #ASHImageBank and share your insights in the comments!….
0
6
0
Wrapping up 2024 with exciting news:.Officially an #ABIM board certified Hematologist & Medical Oncologist!!!
16
0
157
RT @Noha_Soror: Today’s ASH CDEI event was a success!! Thankful to @ASH_hematology for the opportunity and space to connect!.Huge thank yo….
0
7
0
RT @Dr_AmerZeidan: Dr @JMStempel fantastically presented our investigator-initiated randomized phase 2 trial of aza-ven +/- Pembro in older….
0
11
0
RT @Noha_Soror: Looking forward to seeing everyone!.@ASH_hematology @ResearchOU @IMG_Oncologists @HemOncFellows @hemeoncfellow #ASHDEI #ASH….
0
4
0
RT @HemOncFellows: Are you ready to make the most of your experience at #ASH24? We’re excited to introduce a fun and engaging Bingo Card ex….
0
6
0